Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lowell Anthony

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Neuroendocrinology|May 3, 2021
Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH StudyDieter Hörsch, Lowell Anthony, David J Gross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2014
Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumorsJoseph D Valentino, Jing Li, Yekaterina Y Zaytseva, et al.
JCO Oncology Practice|September 30, 2020
Benchmarks for Academic Oncology FacultyLowell Anthony, George Atweh, Ravi Bhatia, et al.
Clinical Therapeutics|October 28, 2017
Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-controlled Study of Telotristat EthylLowell Anthony, Claire Ervin, Pablo Lapuerta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
90Y-edotreotide for metastatic carcinoid refractory to octreotideDavid L Bushnell, Thomas M O'Dorisio, M Sue O'Dorisio, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Neuroendocrinology|May 3, 2021
Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH StudyDieter Hörsch, Lowell Anthony, David J Gross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2014
Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumorsJoseph D Valentino, Jing Li, Yekaterina Y Zaytseva, et al.
JCO Oncology Practice|September 30, 2020
Benchmarks for Academic Oncology FacultyLowell Anthony, George Atweh, Ravi Bhatia, et al.
Clinical Therapeutics|October 28, 2017
Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-controlled Study of Telotristat EthylLowell Anthony, Claire Ervin, Pablo Lapuerta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
90Y-edotreotide for metastatic carcinoid refractory to octreotideDavid L Bushnell, Thomas M O'Dorisio, M Sue O'Dorisio, et al.
Pageof 5